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Summary. Neurotomy is widely used as a model of 
chronic, intractable pain, the proverbial "crux medicor- 
urn". Immunohistochemical aspects of this chronic pain 
model are discussed in this paper, with the aim of shed- 
ding new light on the pathomechanism and possible ther- 
apeutical consequences. 
Central terminals of nociceptive neurons contain sub- 
stance P, somatostatin and calcitonin generelated peptide 
or exhibit fluoride resistant acid phosphatase and thia- 
mine monophosphatase enzyme reaction in the superficial 
dorsal horn of the spinal cord and in analogous tructures 
of the brain stem. These neuropeptides and neuroproteins 
are expressed by the related dorsal root ganglion cells 
and transported via orthograde axoplasmic transport via 
dorsal roots to the central nervous ystem. 
Transection of the ipsilateral, segmentally related per- 
ipheral sensory nerve results in transganglionic degenera- 
tive atrophy of central terminals of primary nociceptive 
neurons. Transganglionic degenerative atrophy is charac- 
terized by marked ultrastructural terations uperficially 
similar to, but essentially differing from the signs of Wal- 
lerian degeneration which ensue after dorsal rhizotomy. 
Transganglionic degenerative atrophy is accompanied by 
depletion of marker neuropeptides and enzymes, and la- 
ter by the expression of vicarious neuropeptides such as 
vasoactive intestinal polypeptide, neuropeptide Y and ga- 
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lanin and of the enzyme choline acetyl transferase. Con- 
sequences of blockade of retrograde axoplasmic transport 
of the nerve growth factor elicited either by perineural 
application of microtubule inhibitors or by perineural ad- 
ministration of anti-nerve growth factor are similar to 
peripheral neurotomy. 
According to recent studies described in this paper, the 
blockade of nerve growth factor supply to primary noci- 
ceptive neurons induces activation of c-jun in nuclei of 
primary nociceptive neurons~ probably responsible for the 
plasticity of the neuropeptide and neuroprotein synthesiz- 
ing machinery. In contrast, invasion of and formation of 
pericellular baskets by noradrenergic axons can be eli- 
cited only by axotomy and not by blockade of retrograde 
axoplasmic transport. Involvement of nerve growth factor 
and the nerve growth factor-dependent immediate arly 
genes in neuroplasticity of neuropeptidergic primary sen- 
sory neurons raise the possibility of a gene therapy of 
chronic intractable pain. 
Key words: Plasticity - Dorsal root ganglion - Axoplas- 
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Introduction 
Retrograde changes in axotomized neurons have been 
well known for more than a century. These alterations, 
known as "chromatolysis" or "tigrolysis" mainly refer to 
the re-arrangement of the endoplasmic reticulum ready 
to synthesize large amounts of neuroproteins destined to 
replace the lost volume of the axon, in motor, sensory 
and autonomic nerve cells. Another feature of axoto- 
mized sensory neurons is their failure to synthesize the 
enzyme acid phosphatase destined for terminals in the 
dorsal horn (Colmant 1959). Ultrastructural nalysis dis- 
closed that, not only did acid phosphatase disappear from 
the central terminals but, at the same time, there ensued 
several fine structural, electron microscopically discern- 
ible alterations in the related terminals. These alterations 
have been summarized under the term degenerative atro- 
phy*, whereby an electron lucent and and an electron 
dense form have been distinguished (Csillik and Knyihfir 
1975; Knyihfir and Csillik 1976). It has been shown that 
transganglionic degenerative atrophy (TDA) of central 
terminals of primary sensory neurons can be evoked by 
blockade of the retrograde axoplasmic transport in the 
segmentally related, ipsilateral peripheral sensory nerve, 
by locally applied microtubule inhibitors such as colchi- 
cine, vinblastine, and vincristine (Csillik et al. 1978). The 
same effect can be elicited by local application of anti- 
nerve growth factor to a peripheral sensory nerve (Csillik 
1984; Csillik et al. 1984; Csillik et al. 1985). 
Neurotomy is widely used as a model system for 
chronic, intractable pain (Bonica 1990). It is known that 
retrograde transport of neurotrophic factors from periph- 
eral tissue to target neurons is necessary to support survi- 
val and maintain normal metabolism and function of 
sensory neurons of dorsal root ganglia (Thoenen and 
Barde 1980; Csillik et al. 1985; Barde 1989; Snider et al. 
1992; Masu et al. 1993). It has been shown in earlier stu- 
dies that, like neurotomy, blockade of the retrograde 
transport mechanism in a peripheral sensory nerve also 
results in depletion of "marker substances" such as neu- 
* The term "atrophy" has to be emphasized since, virtually si- 
multaneously, Grant and Arvidsson (1975) described "transgan- 
glionic degeneration" in trigeminal primary sensory neurons 
after cutting the nerves close to the ganglion. The main differ- 
ence between the two interpretations is that, in the course of de- 
generative atrophy, the terminals do not undergo destruction 
which is evident from the fact that, sooner or later, regeneration 
(sprouting) from these terminals occurs. On the other hand, the 
term transganglionic degeneration (Grant and Arvidsson 1975) 
implies a definite and final decease of the terminal, rendering it
incapable for any further egenerative efforts. In order to stress 
the similarity but not identity of the two processes, we adopted 
the term "transganglionic degenerative atrophy" (TDA) for the 
atrophic alterations which ensue in the dorsal horn after cutting 
the related peripheral sensory nerve, summarized in two major 
papers (Csillik and Knyihgr-Csillik 1987, 1988) and two mono- 
graphs (Knyih~r-Csillik and Csillik 1981; Csillik and KnyihAr- 
Csillik 1986). 
ropeptides like substance P and calcitonin gene-related 
peptide, and neuroproteins such as thiamine monophos- 
phatase and fluoride resistant acid phosphatase from the 
segmentally related, ipsilateral superficial dorsal horn 
(KnyihAr and Csillik 1976; Csillik et al. 1977; Csillik and 
Knyihfir 1982; Knyihgtr-Csillik et al. 1986, 1990; H6kfelt et 
al. 1994). At the same time, various neuropeptides, such 
as vasoactive intestinal peptide (Shehab and Atkinson 
1986), galanin and neuropeptide Y (HOkfelt et al. 1995) 
and the enzyme choline acetyt transferase (Csillik and 
Knyihfir-Csillik 1992) appeared in the same area of the 
dorsal horn from where SR CGRR TMP and FRAP had 
been depleted. 
An entirely new aspect of TDA has been discovered by 
Herdegen et al. (1991): expression of c-jun in nuclei of 
the axotomized ganglion cells, a discovery which has been 
supported by numerous investigations (Gold et al. 1993, 
1994; Kenney and Kocsis 1997, 1998; Broude et al. 1999; 
Buschmann et al. 1999). The correlation between euro- 
peptide plasticity and expression of c-jun seems to be evi- 
dent, but not proved as yet. The neurogenetic approach 
raised several important questions. First, can expression 
of c-]un also be elicited by a local blockade of axoplasmic 
transport with microtubule inhibitors, such as colchicine, 
vinblastine and vincristine? Second, can expression of c- 
jun also be elicited by perineural application of anti- 
NGF around the peripheral sensory nerve? And third, 
can the effect of a peripheral axotomy be counteracted 
by deposition of NGF on the proximal stump of a trans- 
ected sensory nerve? It has been shown previously (Csillik 
et al. 1985) that NGF, deposited to the proximal stump of 
a transected peripheral sensory nerve, delays the normally 
ensuing TDA of the respective central terminals. The 
question arises as to whether or not deposition of NGF to 
the proximal stump of a transected peripheral sensory 
nerve is also able to inhibit the expression of c-jun in the 
nuclei of the related, ipsilateral spinal sensory ganglion? 
Finally, a novel aspect of neurotomy-induced altera- 
tions is the invasion of noradrenergic axons and forma- 
tion of noradrenergic pericellular baskets in related 
dorsal root ganglia which has been described in various 
laboratories (McLachlan et al. 1993; Chung et al. 1993). 
These pericellular baskets contained not only catechola- 
mines but also CGRP (McLachlan et al. 1993). 
The aim of the present study was to decide, on the ba- 
sis of immunohistochemical examination, whether block- 
ade of the retrograde transport of NGF (1) results in 
depletion of marker substances, (2) whether the same 
treatment induces activation of c-jun in nuclei of dorsal 
root ganglion cells, (3) whether this same treatment in- 
duces expression of VIR galanin, NPY and CHAT, and fi- 
nally, (4) whether blockade of axoplasmic transport does 
or does not elicit pericellular sprouting of noradrenergic 
axons in dorsal root ganglia, similarly to neurotomy. At 
the same time, we also sought to answer the question as 
to whether formation of pericellular baskets can be pre- 
vented by deposition of NGF on the proximal stump of 
the transected sciatic nerve. 
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Based on these experiments, an explanation will be at- 
tempted for the mechanism of molecular plasticity in the 
neuropept ide synthesizing mechanism of dorsal root 
ganglion cells, with special regard to the possibilities of 
therapy of chronic pain. A brief account of these studies 
has been published in abstract form (Csillik and Knyihfir- 
Csillik 2000 a, 2000 b). 
Material and methods 
Investigations were performed on 40 young adult albino rats 
(250 g body weight) of both sexes, R-Amsterdam strain. Care of 
the animals complied with the guidelines of the Hungarian Min- 
istry of Welfare. The animals were divided into 5 groups, consist- 
ing of 8 rats each. Group I served as an absolute control. Groups 
2-5 were subjected to various surgical treatments under chloral 
hydrate anesthesia (i.p., 0.4g/kg body weight). Experiments 
were carried out in accordance with the European Communities 
Council Directive (November 24, 1986; 86/609/EEC) and the Al- 
bert Szent-Gy6rgyi Medical University Guidelines for Ethics in 
Animal Experiments. Rats in Group 2 were subjected to unilat- 
eral transection of the sciatic nerve close to the sciatic notch, 
while i cm long piece of the sciatic was excised and the proximal 
stump ligated. Animals in Group 3 received a unilateral cuff 
treatment of the sciatic nerve, close to the sciatic notch; with 
Vincristine ® (Richter, Budapest, Hungary), 0.1 mg in i ml saline, 
by which a perineural Gelaspon ®cuff was soaked (sizes of the 
cuff while dry: 2 x 2 x 10 mm). Group 4 animals were subjected to 
perineural treatment of the sciatic nerve at mid-thigh level, with 
anti-nerve growth factor (anti-NGF, Sigma Immunochemicals, 
N 5142, 0.1 ml dissolved in i ml saline), also in a perineural Ge- 
laspon ® cuff, at mid-thigh level. Animals in Group 5 were sub- 
jected to unilateral transection of the sciatic nerve, close to the 
sciatic notch; the proximal stump was surrounded with a Gelas- 
pon tampon, soaked in NGF (Sigma Immunochemicals) and 
fixed to the severed end of the nerve by Kwik-Sil (World preci- 
sion Instruments Inc, Sarasota, FL, USA). The contralateral scia- 
tic nerves of Group 3 animals were surrounded by Gelaspon ®
cuffs soaked in physiological saline while those of Group 4 ani- 
mals were treated with a Gelaspon ®cuff soaked in pre-immune 
serum. 
Three, 6 and 12 hours, and 1, 2, 3, 10 and 20 days respectively 
after surgery, deep anesthesia was induced with chloral hydrate 
(1 g/kg body weight, i.p.), and, after a brief transcardial flush 
with saline, rats were subjected to transcardial fixation in a pi- 
cro-aldehyde solution (Zamboni and De Martino 1967). After 
fixation, the lumbosacral spinal cord and the related dorsal root 
ganglia were dissected, post-fixed at 4 °C in Zamboni's fixative 
overnight, washed in saline, transferred into an ascending series 
(10%, 20%, 30%) of sucrose and cut at 30 Inn in a cryostat. Sec- 
tions of the spinal cord were incubated overnight at room tem- 
perature for the immunohistochemical demonstration of SR 
CGRP and VIP; sections of dorsal root ganglia L5 and L6 were 
incubated for 1 hour at room temperature for the immunocyto- 
chemical demonstration f c-]un. 
For the immunohistochemical demonstration f SP, a polyclo- 
nal antibody, raised in rabbit by Phoenix Pharmaceuticals Inc 
(Mountain View, CA, USA) and a monoclonal antibody pro- 
duced by Pharmingen (San Diego, CA), was used at a dilution of 
1:4000. CGRP was visualized by the polyclonal antibody (rab- 
bit) produced by Sigma (Sigma-Aldrich, Wien, Austria) at a dilu- 
tion of 1:4000, and VIP was demonstrated by the polyclonal 
antibody raised in rabbit by Phoenix Pharmaceuticals Inc 
(Mountain View, CA, USA), at a dilution of 1:20,000. Samples 
were transferred into the primary antibody (anti-CGRP, Sigma 
RBI, 1:4000) at 4 °C for 36 hours, or at room temperature for 
12 hours. The anti-CGRP serum used in these studies recognizes 
both c~ and 13 CGRP but does not cross-react with calcitonin. 
After incubation in the primary serum, the streptavidin-biotin 
system (ABC, Vectastain Elite, Vector Laboratories) was used. 
The reaction was visualized by diamino-benzidine (DAB) to 
which hydrogen peroxide was added (3 pl of 30% H202 to 10 ml 
of 1% DAB). Finally, c-jun was visualized by the polyclonal anti- 
body produced by Santa Cruz Biotechnology Inc (Santa Cruz, 
CA) at a dilution of 1:200. Samples were pretreated in 2% 
H202 and incubated in a blocking serum consisting of 0.1 M 
phosphate buffered saline, 2% normal goat serum (NGS), 1% 
bovine serum albumin (BSA) and 0.3% Triton X-100, on a sha- 
ker plate at room temperature for 1 hour. Sections were either 
mounted on Silane-pretreated sli es, dehydrated in a graded ser- 
ies of ethanol and processed through carbol-xylene or treated ac- 
cording to the free-floating technique. Slides were coverslipped 
with Permount. 
Specificity of the immunohistochemical reaction was assessed 
either by incubating slides in normal rabbit serum lacking the 
primary antibody, or by pre-absorption f the antiserum with the 
commercially available synthetic rat SE CGRP, or VIP, or by 
omitting steps to visualize the antigen-antibody reaction. Ab- 
sence of any immunohistochemical staining in any of the above 
control experiments proves validity of the immunoreaction in the 
experimental material. 
Immunohistochemical localization of c-jun was performed in 
the dorsal root ganglia L5 and L6 using 30 gm cryostat sections. 
Samples to be stained for c-jun were post-fixed in the same fixa- 
tive for 3 hours. Serial sections were incubated with the polyclo- 
nal primary antibody for c-jun protein (rabbit), obtained from 
Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) at a 
1:200 dilution in PBS with 5% NGS, 1% BSA, 0.1% Triton 
X-100 for 1 hour at room temperature. Using the avidin-biotin 
technique; visualization of the reaction product in the c-jun ex- 
pressing cells was performed with nickel-DAB as described by us 
earlier (Csillik et al. 1998). 
Norepinephrine fluorescence was studied in normal and ex- 
perimental dorsal root ganglia L5 according to the "vacuumless 
freeze-dry" technique described earlier (Csillik and K~ilm~in 
1967). Accordingly, cryostat sections obtained from fresh, non- 
fixed material were dried over phosphorous pentoxide for 
20 hours at -20 °C followed by room temperature for 10 hours; 
thereafter, the dry sections were subjected to formaldehyde gas 
treatment according to Carlsson et al. (1961) and Hillarp et al. 
(1966). Sections were mounted in Entellau and studied by means 
of a Nikon epifluorescence microscope. 
The number of nerve cells expressing strong or medium c-jun 
immunoreactivity, respectively, was determined in randomly se- 
lected serial sections of the ganglia cut longitudinally. The reac- 
tive cells were counted by a person unaware of the experimental 
parameters. 
For electron microscopy, samples were fixed in a paraformalde- 
hyde-glutaraldehyde mixture, postfixed in buffered osmic acid, 
dehydrated and embedded in an Araldite-Durcupan mixture. Se- 
rial sections, silver interference colour, were obtained on a Reich- 
ert Ultrotome, stained with lead citrate and uranyl acetate, and 
studied on JEOL 100 and JEOL 1010 electron microscopes. 
Densitometry. lmmunostained sections were viewed on a Ni- 
305 
kon Microphot FX1 microscope. Microscopic fields were con- 
verted into black and white digital images by means of an MTI 
CCD 72 video camera nd amplifier and transferred to a Macin- 
tosh Quadra 700 computer running the NIHImage 1.55 b image 
analysis oftware. The gray level of the selected area was mea- 
sured using the mean density option of the computer program. 
The intensity of the immunoreaction in the dorsal horn was mea- 
sured in the medial and in the lateral halves of the superficial 
dorsal horn on the experimental side, and in the medial part of 
the control (contralateral) side, using a densitometric analysis of 
the immunostained sections. Measurements of the optical density 
were made from similar, selected areas of the ipsilateral and the 
contralateral dorsal horns, in 10 randomly selected sections of 
each animal. A total of about 2500 areas of control and experi- 
mental sides of the animals were measured. The images were 
captured irectly from the microscope slid s, using a 5x objective 
lens and displayed on a computer monitor. The software automa- 
tically assigned the average gray values of the pixels seen on the 
screen; a value of 0 indicated a white pixel and 255 indicated a
black pixel. Analysis of the data was performed with one- and 
two-tailed Student's t test. 
For the statistical analysis of c-jun immunoreactive c lls, the 
Mann-Whitney u-test was used since the values of strongly reac- 
tive, medium and non-reactive cells were non-parametrical. For 
repeated measures, the ANOVA technique was used. 
Results 
Transection of the sciatic nerve 
The consequence of transection of a per ipheral  sensory 
nerve is the disappearence of marker  substances (the neu- 
ropeptides SP and CGRP and the enzymes FRAP and 
TMP) from central terminals of pr imary nociceptive neu- 
rons and activation of c-]un in the dorsal root ganglion. 
Coincident with the deplet ion of the marker  substances, 
Fig. 1. Submicroscopic equivalents of ransganglionic degenerative atrophy w ich leads to depletion of marker enzymes and neuro- 
peptides. Lamina II of the spinal cord of the Macacus rhesus monkey. 
1 a. electron microscopy of the normal control (contralateral) side. The afferent central terminals display the structure of dense sinus- 
oid axons (DSA), often coupled with each other by means of attachment placques (AP). gl: glial filaments 
lb:  electron dense type of transganglionic degenerative atrophy, 9 days after transection of the ipsilateral sciatic nerve. Note the per- 
sistence of synaptic vesicles (sv) within the darkened terminal. 
1 c. Final stage of electron dense transganglionic degenerative atrophy: engulfment of the terminal 21 days after transection of the ip- 
silateral, segmentally related peripheral nerve. 
1 d. Electron lucent type of transganglionic degenerative atrophy. Arrow within the terminal indicates a tubular structure giving rise 
to synaptic vesicles. Eleven days after transection of the ipsilateral, segmentally related peripheral nerve. 
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atrophic alterations of the central terminals were ob- 
served by electron microscopy. The atrophic alterations 
were either of the electron dense type, that occasionally 
culminated in glial engulfment of the atrophied terminal,  
or of the electron lucent type (Fig. 1). 
Time course and the extent of the depletion depend on 
the site of transection. In the present studies, the sciatic 
was transected close to the sciatic notch; thus, the first 
signs of deplet ion of FRAP and TMP could be observed 
as early as 3 days after surgery and; at 10 days, deplet ion 
of FRAP and TMP was complete. In this context, it 
should be noted, however, that in the most lateral port ion 
of the superficial dorsal horn, representing the postaxial 
dermatome, supplied by the dorsal branches of the spinal 
nerves which, of course, were not damaged when the scia- 
tic nerve was transected, there no changes could be ob- 
served in TMP or FRAP reactivity. 
In contrast to the two marker  enzymes FRAP and 
TMP, deplet ion of the neuropept ides SP and CGRP was 
only partial. In addition, visible diminution of neuropep- 
tide expression in the superficial aminae of the dorsal 
horn started slightly later, i.e. on the 5th or 6th post- 
operative day. Here again, in the most lateral port ion of 
the superficial dorsal horn, representing the postaxial der- 
matome, supplied by the dorsal branches of the spinal 
nerves which were not damaged when the sciatic nerve 
was transected, there no changes could be seen in SP and 
CGRP content. 
On the fourth day after transection of the sciatic nerve, 
the enzyme ChAT began to be expressed in the dorsal 
horn. ChAT is virtually absent from the dorsal horn under 
normal conditions; however, it is expressed in laminae I, 
I I  and I I I  after neurotomy. Later, 10-14 days after the 
surgery, deplet ion of SP and CGRP is fol lowed by the 
expression of VIP, NPY and galanin. Coincident with 
the expression of these "vicarious" neuropeptides, the 
amount of GFAP expressed by astrocytes is dramatical ly 
increased (Table 1). 
Expression of c-jun started very early. While, under 
normal conditions, 88 + 4% of L5 dorsal root ganglion 
cells were entirely devoid of the c-jun reaction product 
and only 12 + 4% of the cells exhibited a moderate reac- 
tion, 5 hours after transection of the sciatic, 92 + 8% of 
the nerve cells in the L5 dorsal root ganglion became 
strongly c-jun reactive; 7 + 3% expressed moderate inten- 
sity and only 1 + 1% were non-reacting. The values of in- 
tensely and moderately reacting cells persisted virtually 
unchanged during the first and second postoperative 
weeks, but started to decline steadily as soon as the be- 
ginning of VIP (and NPY and galanin) expression. 
Two weeks after transection of the sciatic nerve, sprout- 
ing of norepinephrine-containing axons was evident in 
the ipsilateral dorsal root ganglion L5. The number of 
per±cellular baskets increased continuously over time; two 
months postoperatively, 40+ 13% of the ganglion cells 
were surrounded by noradrenergic sprouts. Most of the 
per±cellular baskets expressed CGRP immunoreactivity, 
but there was no effort to compare the numbers of nora- 
drenergic and neuropeptidergic per±cellular baskets 
(rig. 2). 
Table 1. Depletion of SR CGRP, FRAP and TMP from the ipsilateral, segmentally related superficial dorsal horn after neurotomy 
(1-2), after per±neural pplication of a microtubule inhibitor (3-5) and after per±neural pplication of anti-NGF (6-9). Densitometric 
values (averages of 10 determinations ± SD) in the contralateral (C, control) superficial dorsal horn, and in the medial (M) and lat- 
eral (L) half of the superficial dorsal horn in the experimental side. Values refer to laminae I-I I I  for SP and CGRR and to lamina II 
for FRAP and TMR Background ensity deducted in each case. The p values indicate significance between the differences of optical 
densities in the medial and lateral halves of the superficial dorsal horn in the experimental side. (po = postoperative) 
No Experiment Killed on SP CGRP FRAP TMP 
1. neurotomy po. day 7 C: 82 + 8; M: 42 ± 6; L: C: 79 ± 8; M: 40 + 4; C: 80 + 8; M: 7 ± 3; 
80 ± 9; p < 0.01 L: 78 ± 8; p < 0.01 L: 80 + 9; p < 0.001 
2. neurotomy po. day 5 C: 82 _+ 8; M: 78 ~+ 8; C: 80 + 8; M: 76 + 6; C: 78 _+ 8; M: 15 _+ 3; 
L: 81 + 9; p = 1 L: 78 _+ 9; p = 1 L: 75 ± 4; p < 0.01 
3. vincristine po. day 7 C: 81 _+ 5; M: 56 ± 5; C: 78 ± 6; M: 53 ± 6; C: 78 ± 4; M: 10 ± 2; 
L: 81 + 7; p < 0.01 L: 80 ± 8; p < 0.01 L: 76 + 3; p < 0.01 
4. vincristine po. day 5 C: 80 + 5; M: 74 ± 5; C: 81 + 5; M: 76 ± 5; C: 79 + 5; M: 57 + 5; 
L: 81±7; p = 1 L: 81±5; p = 1 L: 81±7; p = 0.1 
5. vincristine po. day 9 C: 81 ± 5; M: 45 _+ 5; C: 85 + 5; M: 51 ± 5; C: 80 ± 4; M: 8 + 2; 
L: 81 ± 7; p < 0.01 L: 81 ± 7; p < 0.01 L: 76 ± 3; p < 0.001 
6. anti-NGF po. day 5 C: 82 ± 8; M: 78 :t: 8; C: 80 + 8; M: 76 ± 6; C: 79 ± 5; M: 77 ± 5; 
L: 81±9; p -- 1 L: 78±9; p= 1 L: 81±7;p= 1
7. anti-NGF po. day 7 C: 80 ± 5; M: 52 ± 5; C: 78 + 6; M: 53 + 6; C: 81 ± 5; M: 80 ± 5; 
L: 81 ± 7; p < 0.01 L: 80 _+ 8; p < 0.01 L: 81 _+ 7; p = 1 
8. anti-NGF po. day 9 C: 85 ± 5; M: 52 ± 5; C: 79 + 6; M: 53 + 6; C: 78 ± 8; M: 19 ± 3; 
L: 84 + 7; p < 0.01 L: 80 ± 8; p < 0.01 L: 75 ± 4; p < 0.01 
9. anti-NGF po. day 11 C: 83 ± 5; M: 55 +_ 5; C: 79 ± 6; M: 55 ± 6; C: 79 ± 8; M: 20 + 3; 
L: 82 ± 7; p < 0.01 L: 79 ± 8; p < 0.01 L: 74 ± 4; p < 0.01 
C: 72 + 8; M: 8 + 1; 
L: 72 + 9; p < 0.001 
C: 72 + 6; M: 14 + 4; 
L: 70 + 5; p < 0.01 
C: 74 ± 4; M: 8 + 2; 
L: 72 + 3; p < 0.01 
C: 86 + 5; M: 52 + 5; 
L: 85 + 7; p = 0.1 
C: 78 + 4; M: 10 + 2; 
L: 76 ± 3; p < 0.001 
C: 77 ± 5; M: 77 ± 5; 
L: 81 ± 7; p = 1 
C: 78 + 6; M: 83 + 6; 
L: 80+8;p= 1
C: 72 ± 6; M: 18 + 4; 
L: 70 + 5; p < 0.01 
C: 75 ± 6; M: 19 + 4; 
L: 76 ± 5; p < 0.01 
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Fig. 2. Catecholamine fluorescence of pericellular bakets. 
2 a. Control (contralateral) ganglion. Except for a few fragments of perivascular nerve fibers (arrows), there is no catecholamine 
fluorescence present. Note autofluorescent pigment granules in the cytoplasm of a ganglion cell (asterisk). x 1200 
2b. Dorsal root ganglion L5, 2 months after transection of the sciatic nerve. Most of the ganglion cells are surrounded by pericellular 
catecholamine baskets (arrow). x 1200 
Blockade of axoplasmic transport 
Perineural application of microtubule inhibitors, such as 
colchicine (10-6-10 -8 M), vinblastine (10-6-10 -7 M), vin- 
cristine (10-6-10 -8 M), formyl-leurosin (10-6-10 -8 M), gri- 
seofulvin (10-2-10 -6 M), podophyllotoxin (10-6 M) around 
the peripheral sensory nerve resulted in depletion of 
FRAP, TMP (Fig. 3), SP and CGRP from central nocicep- 
tive terminals and activation of c-jun in the segmentally 
related, ipsilateral dorsal root ganglion (Fig. 4). Twelve 
hours after perineural application of the microtubule 
inhibitor vincristine (10 .8 M) around the sciatic nerve, 
50 + 8% of the nerve cells in the L5 dorsal root ganglion 
were strongly c-jun reactive, 8 + 4% expressed medium 
intensity and 42 + 2% were non-reacting. On the fourth 
day after perineural anti -NGF treatment (Table 2), the 
enzyme ChAT started to be expressed in the dorsal horn. 
Depletion of SR SS and CGRP was partial, followed by 
expression of VIR NPY and galanin during the second 
Fig. 3. Effect of a perineural Vincristine cuff (10 4 M, for 7 days) on the thiamine monophosphatase (TMP) reactivity of the segmen- 
tally related superficial dorsal horn. At the left, the normal reaction can be observed, confined to lamina II of the spinal cord. The 
line of the reaction consists of thousands of individual central sensory nerve endings, each displaying TMP reactivity. At the right, 
the depletion of TMP from the medial aspect of lamina II is apparent, x 50 
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Fig. 4. Expression of c-jun by nuclei of the ganglion cells. 
4 a. On the contralateral (control) side, only a few, scattered nu- 
clei exhibit a very weak c-jun reaction, x 400 
4 b. Twelve hours after perineural vinblastine treatment (10 -7 M) 
c-jun is expressed by nearly every ganglion cell nuclei, x 400 
and third postoperative weeks. After re-establishment of 
NGF transport in peripheral sensory axons, vicarious neu- 
ropeptides (VIR NPY and galanin) disappeared and the 
original neuropeptides and the marker enzymes re-ap- 
peared in the central terminals of primary nociceptive 
neurons; expression of c-jun in dorsal root ganglion cells 
was discontinued as soon as the retrograde NGF trans- 
port in the peripheral sensory nerve was re-established. 
Coincident with the expression of vicarious neuropep- 
tides, the amount of astrocytes expressing GFAP was con- 
siderably increased after perineural application of 
microtubule inhibitors. 
Perineural Vincristine (10 -s M) or Vinblastin treatment 
(10 -6 M) did not induce formation of pericellular baskets 
in the segmentally related, ipsilateral dorsal root gang- 
lion. 
Blockade of retrograde axoplasmic transport of NGF by means 
of perineurai application of anti-NGF 
Perineural treatment of the sciatic nerve with anti-NGF 
(0.1 ml diluted to 1 ml, and applied in a Gelaspon cuff) 
induced disappearence of FRAP and TMP from central 
terminals (Fig. 5) and activation of c-jun in the dorsal 
root ganglion, similar to microtubule inhibitors (Table 2). 
Forty-eight hours after perineural anti -NGF treatment of 
the sciatic, 55 + 10% of the nerve cells in the L5 dorsal 
root ganglion were found to be strongly c-jun reactive, 
18 + 8% expressed medium intensity and 27 + 8% were 
non-reacting (Table 3). On the fourth day after perineural 
anti -NGF treatment, he enzyme ChAT started to be ex- 
Table 2. Expression of VIE ChAT and GFAP in the ipsilateral, segmentally related superficial dorsal horn after neurotomy (1-2), 
after local perineural pplication of a microtubule inhibitor (3-5) and after perineural pplication of anti-NGF (6-9). Densitometric 
values (averages of 10 determinations + SD) in the contralateral (C, control) and in the medial (M) and lateral (L) half of the superfi- 
cial dorsal horn in the experimental side. The p values indicate significance between the differences of optical densities in the super- 
ficial dorsal horn on the experimental side versus the control (contralateral) side. (po = postoperative) 
No Experiment Killed on VIP ChAT GFAP 
1. neurotomy po. day 7 C: 5 + 3; M: 5 + 3; C: 5 + 3; M: 62 + 4; 
L: 4 + 3; p = 1 L: 12+ 3; p < 0.01 
2. neurotomy po. day 14 C: 5 + 3; M: 52 + 3; C: 6 + 3; M: 63 + 4; 
L: 4 + 3; p < 0.01 L: 14 + 3; p < 0.01 
3. vincristine po. day 7 C: 5 + 3; M: 5 _+ 3; C: 5 + 3; M: 65 + 3; 
L: 4 + 3; p = 1 L: 14+ 3; p = 0.01 
4. vincristine po. day 14 C: 5 + 3; M: 55 + 3; C: 5 + 3; M: 8 + 4; 
L: 4 + 3; p < 0.01 L: 2 + 3; p = 1 
5. vincristine po. day 21 C: 6 +_ 3; M: 58 + 3; C: 6 + 3; M: 7 + 4; 
L: 9 + 4; p < 0.01 L: 5+3;p= 1
6. anti-NGF po. day 5 C: 5 + 3; M: 4 _+ 3; C: 5 + 3; M: 8 + 4; 
L :4+3;p=l  L :2+3;p=1 
7. anti-NGF po. day 7 C: 5 + 3; M: 34 + 3; C: 5 + 3; M: 38 + 4; 
L: 14 + 3; p = 0.1 L: 22 + 3; p = 0.01 
8. anti-NGF po. day 14 C: 6 + 3; M: 58 + 3; C: 8 + 3; M: 48 + 3; 
L: 9 + 4; p < 0.01 L: 9 + 4; p < 0.01 
9. anti-NGF po. day 21 C: 5 + 3; M: 4 _+3; C: 5 + 3; M: 8 + 4; 
L :4+3;p=l  L :2+3;p=1 
C: 12 + 3; M: 3 + 3; 
L: 11+3;p=1 
C: 10 + 3; M: 53 _+ 8; 
L: 11+3; p = 1 
C: 11 + 3; M: 3+3; 
L: 11+3;p= 1 
C: 12 + 3; M: 58 _+ 8; 
L: 10 + 3; p < 0.01 
C: 11 + 3; M: 82 _+ 8; 
L: 56 + 3; p < 0.001 
C: 12 + 3; M: 8 + 8;
L :56+3;p=l  
C: 12 + 3; M: 53 _+ 8; 
L: 3+_3; p=0.1 
C: 12 + 3; M: 83 + 8; 
L: 3+3; p = 0.01 
C: 12+3; M: 8+8; 
L :7_+3;p=l  
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pressed in the dorsal horn. Depletion of SR SS and 
CGRP was partial, followed by expression of VIE NPY 
and galanin during the second and third postoperative 
weeks. After reestablishment of NGF transport in periph- 
eral sensory axons, vicarious neuropeptides VIR NPY and 
galanin disappeared and the original neuropeptides and 
enzymes re-appeared in the central terminals of primary 
nociceptive neurons; simultaneously, expression of c-inn 
in dorsal root ganglion cells was discontinued as soon as 
the retrograde NGF transport in the peripheral sensory 
nerve was re-established. Coincident with the expression 
of vicarious neuropeptides, the amount of astrocytes ex- 
pressing GFAP was greatly increased after perineural ap- 
plication of anti-NGF. 
Perineural ant i -NGF treatment did not induce sprout- 
ing of eatecholaminergic nerve fibers and the formation 
of pericellular baskets in the segmentally related, ipsilat- 
eral dorsal root ganglia. 
Fig. 5. Effect of a perineural nti-NGF cuff (9 days) on the substance P (SP) immunoreaction f the superficial dorsal horn. At the 
left, the normal reaction can be observed, present in laminae I-I I- I I I  of the spinal cord. The strongest reaction can be seen in lamina 
II, also laminae I and lamina III but react. The immunoreaction consists of thousands of individual central sensory nerve endings, 
each displaying SP reactivity. At the right, the depletion of SP, though less conspicuous than that of TMP, is apparent in the medial 
aspect of lamina II. x 32 
Table 3. Expression of c-jun in the ipsilateral, segmentally related dorsal root ganglia under normal conditions (1) after neurotomy 
(2-9), after perineural pplication of a microtubule inhibitor (10-15) and after perineural pplication of anti-NGF (16-20). 
No Experiment Killed Non-reacting Medium Intense 
postop. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
17. 
18. 
19. 
20. 
control 
neurotomy 
neurotomy 
neurotomy 
neurotomy 
neurotomy 
neurotomy 
neurotomy 
neurotomy 
vincrmtine 
vincnstine 
vincristine 
vincnstine 
vincrlstine 
vincristine 
anti-NGF 
anti-NGF 
anti-NOF 
anti-NGF 
anti-NGF 
0 hr 88 + 4% 12 + 4 
1 hr 85 + 8% 14 + 2% 
5 hr 41 + 12% 7 + 3% 
12 hr 32 + 3_1% 5 + 4% 
24 hr 22 + 12% 6 _+3% 
48 hr 22 + 12% 5 + 5% 
6 days 22 + 15% 6 + 6% 
14 days 23 _+ 13% 6 + 5% 
21 days 18 + 10% 34 + 11% 
lhr  82+8% 14+2% 
5 hr 78 + 8% 14_+ 2% 
12 hr 42 + 22% 8 + 4% 
24 hr 34 + 12% 6 + 4% 
48 hr 23 + 12% 6 + 6% 
6 days 26+ 13% 7+6% 
1 hr 83 + 16% 12 + 7% 
12 hr 78_+21% 14_+7% 
24 hr 75 + 23% 15 _+ 7% 
48 hr 27 _+ 8% 18 + 8% 
6 days 80 + 18% 11 + 8% 
0%,p=1 
0%,p=1 
52 + 8%, p < 0.01 
62 + 7%, p < 0.001 
72 + 7%, p < 0.001 
73 _+ 6%, p < 0.001 
72 + 8%, p < 0.001 
71 + 8%, p < 0.001 
48 + 14%, p < 0.001 
4_+0%,p=1 
8+4%,p<1 
50_+8%, p < 0.1 
60 _+ 10%, p < 0001 
71 + 10%, p < 0.001 
67 _+ 18%, p < 0.001 
5+4%,p=1 
8+4%,p=1 
10+4%, p < 0.1 
55 _+ 10%, p < 0.01 
9+7%,p<0.1 
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Application of NGF at the proximal stump of a transected nerve 
In  accordance with the results of previous invest igat ions 
(Csill ik 1984; Csillik et al. 1985), NGF deposited at the 
proximal  stump of a transected nerve delayed deplet ion 
of SP and FRAR Depos i t ion of NGF to the proximal  
stump of the transected sciatic nerve delayed deplet ion 
of TMP and CGRP from the related dorsal horn  by 2 -  
4 days and prevented the expression of V IP  and ChAT 
for one week (Table 4). Local NGF t reatment  of the 
proximal s tump of the transected sciatic nerve prevented 
the increased expression of GFAP in the ipsi lateral dor- 
sal horn  of the segmental ly related segments of the 
spinal cord. In addit ion, this t reatment  also prevented or 
at least delayed expression of c-fun in nuclei  of the ipsi- 
lateral, segmental ly re lated dorsal root gangl ion (Ta- 
ble 5). On  the other hand, NGF t reatment  of the 
proximal  stump of the transected sciatic nerve did not  
prevent  format ion of catecholaminergic and neuropept i -  
dergic pericel lular baskets in the ipsilateral, segmental ly 
related dorsal root ganglia. 
Table 4. Expression of SR CGRR FRAR TMR VIE ChAT and GFAP in the ipsilateral, segmentally related superficial dorsal horn 
after local deposition of NGF at the proximal stump of the transected sciatic nerve. Densitometric values (averages of 10 determina- 
tions) in the contralateral (C, control) superficial dorsal horn, and in the medial (M) and lateral (L) halves of the superficial dorsal 
horn in the experimental side. Values refer to laminae I- I I I  for SP and CGRR and to lamina II for FRAP and TME Background 
density deducted in each case. The p values indicate significance between the differences of optical densities in the medial and lateral 
halves of the superficial dorsal horn in the experimental side,or those between the experimental nd the contralateral (control) sides. 
po = postoperative day 
No Experiment Killed SP CGRP FRAP TMP VIP ChAT GFAP 
1. neurotomy +NGF po. 1 C: 64 + 4; C: 65 + 4; C: 75 + 4; C: 68 +_ 4; C: 5 + 4; C: 6 + 4; C: 11 + 4; 
M: 62 + 3; M: 64 + 3; M: 68 + 3; M: 64 + 5; M: 4 + 5; M: 4 + 5; M: 10 + 5; 
L: 64 + 2; L: 66 -2-- 2; L: 78 + 2; L: 66 + 2; L: 6 + 2; L: 6 + 2; L: 6 + 2; 
p=l  p=l  p=l  p=l  p=l  p=l  p=l  
2. neurotomy +NGF po. 2 C: 66 + 4; C: 64 + 4; C: 77 + 4; C: 69 + 4; C: 4 + 4; C: 5 + 4; C: 10 + 4; 
M: 63 + 3; M: 64 + 3; M: 69 + 3; M: 69 + 3; M: 4 + 5; M: 4 + 5; M: 11 + 5; 
L: 68 + 2; L: 66 + 2; L: 79 + 2; L: 63 _+ 2; L: 6 + 2; L: 6 + 2; L: 6 + 2; 
p=l  p=l  p=l  p=l  p=l  p=l  p=l  
3. neurotomy +NGFn po. 3 C: 68 + 4; C: 65 + 4; C: 75 + 4; C: 67 + 4; C: 5 + 4; C: 6 + 4; C: 11 + 4; 
M: 65 + 3; M: 68 + 3; M: 65 + 3; M: 62 + 5; M: 3 + 5; M: 4 + 5; M: 10 + 5; 
L: 68 + 2; L: 62 + 2; L: 76 + 2; L: 66 5: 2; L: 6 + 2; L: 6 + 2; L: 6 + 2; 
p=l  p=l  p=l  p=l  p=l  p=l  p=l  
4. neurotomy +NGF po. 4 C: 67 + 4; C: 66 + 4; C: 75 + 4; C: 65 +_ 4; C: 6 + 4; C: 7 + 4; C: 10 + 4; 
M: 65 + 3; M: 68 + 3; M: 65 + 3; M: 62 + 5; M: 3 + 5; M: 4 _+ 5; M: 11 + 5; 
L: 68 + 2; L: 62 + 2; L: 76 + 2; L: 66 _+ 2; L: 7 + 2; L: 6 _ 2; L: 6 + 2; 
p=l  p=l  p=l  p=l  p=l  p=l  p=l  
5. neurotomy +NGF po. 5 C: 68 + 4; C: 65 + 4; C: 75 + 4; C: 67 + 4; C: 5 5: 4; C: 6 + 4; C: 11 + 4; 
M: 65 + 3; M: 68 + 3; M: 65 + 3; M: 62 + 5; M: 3 + 5; M: 4 _+ 5; M: 10 + 5; 
L: 68 + 2; L: 62 + 2; L: 76 + 2; L: 66 + 2; L: 6 + 2; L: 6 + 2; L: 6 + 2; 
p=l  p=l  p=l  p=l  p=l  p=l  p=l  
6. neurotomy +NGF po. 7 C: 69 _+ 4; C: 65 + 4; C: 76 + 4; C: 67 + 4; C: 5 + 4; C: 6 + 4; C: 11 + 4; 
M: 65 + 3; M: 68 +_ 3; M: 60 + 3; M: 58 + 5; M: 3 + 5; M: 14 + 5; M: 10 + 5; 
L: 68 + 2; L: 62 + 2; L: 76 + 2; L: 66 + 2; L: 6 + 2; L: 6 + 2; L: 6 + 2; 
p=l  p=l  p<0.1 p<0.1 p=l  p<0.1 p=l  
7. neurotomy +NGF po. day 10 C: 69 + 4; C: 65 + 4; C: 76 + 4; C: 67 + 4; C: 5 + 4; C: 6 + 4; C: 11 + 4; 
M: 42 + 3; M: 50 + 3; M: 40 + 3; M: 43 + 5; M: 15 + 5; M: 8 _+ 5; M: 39 + 5; 
L: 60 + 2; L: 68 + 2; L: 74 + 2; L: 66 + 2; L: 6 + 2; L: 6 + 2; L: 31 + 2; 
p<0.1 p<0.1 p<0.1 p<0.1 p<0.1 p < 0.01 p<0.1 
8. neurotomy +NGF po. day 14 C: 69 + 4; C: 66 + 4; C: 78 + 4; C: 67 + 4; C: 5 + 4; C: 6 + 4; C: 10 + 4; 
M: 30 + 3; M: 41 + 3; M: 40 + 3; M: 33 + 5; M: 29 + 5; M: 7 _+ 5; M: 42 + 5; 
L: 61 + 2; L: 68 + 2; L: 74 + 2; L: 68 + 62; L: 6 + 2; L: 6 + 2; L: 30 + 2; 
p < 0.01 p < 0.01 p < 0.1 p < 0.01 p < 0.01 p < 0.01 p < 0.01 
9. neurotomy +NGF po. day 21 C: 69 + 4; C: 64 + 4; C: 76 + 4; C: 67 + 4; C: 5 + 4; C: 7 + 4; C: 12 + 4; 
M: 25 + 3; M: 31 + 3; M: 12 + 3; M: 11 + 35; M: 29 + 5; M: 6 5: 5; M: 55 5: 5, 
L: 60 + 2; L: 66 + 2; L: 74 + 2; L: 68 5: 62; L: 6 + 2; L: 8 + 2; L: 30 + 2; 
p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 p < 0.01 
(neuroglial 
transfer) 
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Table 5. Expression of c-jun in nuclei of ganglionic ells of the ipsilateral, segmentally related orsal root ganglia after local deposi- 
tion of NGF on the proximal stump of the transected sciatic nerve following neurotomy. 
No Experiment Killed on day Non-reacting Medium Intense 
1. neurotomy + NGF po. 1 87 _+ 12% 1 + 12% 
2. neurotomy + NGF po. 2 82 + 13% 14 + 12% 
3. neurotomy + NGF po. 3 85 + 1% 13 + 10% 
4. neurotomy + NGF po. 4 68 + 1% 31 + 17% 
5. neurotomy + NGF po. 5 62 + 22% 36 + 15% 
6. neurotomy + NGF po. 6 60 + 24% 16 _+ 11% 
7. neurotomy + NGF po. 7 82 + 26% 16 + 7% 
o+o%,p=1 
4+2%,p<1 
2+2%,p<1 
1+1%,p<0.1 
2+2%,p<0.1 
24 + 12%, p < O.Ol 
2+2%,p<O.1 
Discussion 
Data obtained in the course of the present investigations 
suggest hat NGF plays a crucial role in the plasticity of 
pain-related neuropeptides and enzymes in the superficial 
layers of the dorsal spinal cord. This follows from the fact 
that, with the single exception of pericellular sprouting of 
noradrenergic axons in the dorsal root ganglion, all the 
consequences of neurotomy can be mimiced with an aspe- 
cific blockade of the retrograde axoplasmic transport by 
perineural application of microtubule inhibitors and, spe- 
cifically, with the perineural application of anti-NGE 
However, it is not only the blockade of NGF which 
proves the correlation between NGF and plasticity; the 
fact that application of NGF to the proximal stump of the 
transected sciatic nerve delays or prevents depletion from 
the superficial dorsal horn of the pain-related neuropep- 
tide SP (Csillik et al. 1984; Csillik 1984) and at least one 
of the pain-related enzymes, FRAP (Csillik et al. 1985), 
proves the validity of the assumption that NGF is closely 
related to plasticity phenomena in the dorsal horn. It has 
been reported, furthermore, that instillation of NGF pre- 
vents neurotomy-induced depletion of SP and CGRP 
(Verge et al. 1995). On the other hand, NGF was shown 
to prevent expression of c-jun in dorsal root ganglia 
(Gold et al. 1993). 
The present studies completed this picture insofar that 
not only depletion of FRAP and SR but also that of TMP 
and CGRP can be prevented or delayed by local applica- 
tion of NGF to the proximal stump of the transected 
nerve; also the expression of VIP (and NPY and galanin), 
ChAT and GFAP can be delayed by this same interven- 
tion. 
Taken together, the present observations suggest hat 
(1) expression of c-jun in nuclei of nerve cells of the dor- 
sal root ganglion is caused by the blockade of the nor- 
mally occurring retrograde axoplasmic transport of NGF 
in the peripheral sensory nerve, and (2) that c-jun has a 
dual effect: in addition to upregulating the expression of 
the vicarious neuropeptides VIR NPY and galanin, and 
the enzyme CHAT, in the first phase of the plasticity cir- 
cle, it induces depletion of the pain-related neuropeptides 
SP and CGRP and the enzymes FRAP and TMR by 
down-regulating their expression i  the ganglion. 
The fact that anti-NGF induces depletion not only of 
SP and CGRP but also of FRAP and TMP seems to be 
controversial at first glance. According to Snider and 
McMahon (1998), in dorsal root ganglion cells containing 
SP and CGRP, tyrosine kinase TrkA acts as an NGF re- 
ceptor which remains highly active during ontogeny. Con- 
versely, TrkA is down-regulated after birth in the rest of 
dorsal root ganglion cells which, at the same time, up-reg- 
ulate another tyrosine kinase, Ret, which functions as the 
receptor of the glial cell derived neurotrophic factor 
GDNF. It is assumed that, while those dorsal root gang- 
lion cells that express SP and CGRR are capsaicin sensi- 
tive and subserve inflammation-induced hyperalgesia, the 
group containing TMP and FRAP subserves mechanical 
supersensitivity. According to Snider's and McMahon's 
theory, dorsal root ganglion cells expressing FRAP and 
TMP should be only GDNF sensitive and not NGF sensi- 
tive. Another point which renders the effect of NGF on 
TMP and FRAP-containing dorsal root ganglion cells 
controversial is that, according to Zhou et al. (1999), axo- 
tomized dorsal root ganglion cells develop dependence 
on BDNF or brain-derived neurotrophic factor (Xian and 
Zhou 1999). 
This seemingly controversial situation might be re- 
solved and the controversies seemingly inherent be ex- 
plained on hand of recent studies by Mendell et al. 
(1999). According to Mendell's studies (1999) each of the 
neurotrophic factors BDNF, GDNF, NT-3 and NT-4/5 acts 
in concert with NGF. The functional dependence of these 
neurotrophic factors on NGF might explain depletion of 
FRAP and TMP caused by perineurally applied anti- 
NGF even though dorsal root ganglion cells expressing 
these two enzymes are primarily BDNF-dependent. 
Expression of ChAT in the dorsal horn, beginning on 
the 4th day after axotomy, which has been noted by us 
previously (Csillik and Knyih~r-Csillik 1992) seems to be 
correlated with the expression of VIE It has been shown 
(Luine et al. 1984) that addition of VIP to brain homoge- 
hates increases the activity of CHAT, suggesting a VIP- 
cholinergic interaction in the central nervous system. In 
fact, many of the ChAT-positive nerve cells in the cere- 
bral cortex contain VIP (Eckenstein and Baughman 
1984). Though the expression of VIP in the dorsal horn 
occurs slightly later than the appearence of CHAT, it can 
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be assumed that, under the influence of c-jun which is ac- 
tivated by axotomy several hours after blockade of the 
retrograde axoplasmic transport, the subliminal amount 
of VIP which is not accessible for light microscopic im- 
munohistochemical methods at this early phase of the 
plasticity cycle, is already sufficient o initiate expression 
of CHAT. 
The role of NGF and SP in nocieeption and chronic 
pain seems to be complicated or even controversial in the 
light of recent investigations. According to Lewin and 
Mendell (1993) NGF may serve as a critical link between 
inflammation and hyperalgesia in the adult animal. In 
fact, it has been shown (Lewin et al. 1992) that when 
NGF was artificially increased in a peripheral target, it 
could sensitize central neurons to afferent inputs arising 
from the innervated target. Furthermore, NGF treatment, 
even with a single systemic injection, led to a rapid and 
long-lasting thermal and mechanical hyperalgesia in the 
adult rat which seemed to have both peripheral and cen- 
tral mechanisms. It has been reported that mice which 
over-expressed NGF in the skin displayed an intense hy- 
peralgesia to noxious mechanical stimulation (Davis et al. 
1993). Virtually identical results were obtained recently 
by McLeod et al. (1999) who reported that transgenic 
mice, which over-expressed NGF and SR exhibited allo- 
dynia and hyperalgesia, which was reversed by SP- and 
NMDA-antagonists. 
On the other hand, according to the present results it 
is not NGF, but rather its failure to reach dorsal root 
ganglia, that is the factor responsible for the expression 
of c-jun and hence for the depletion of "pain-related 
neuroproteins" from the dorsal horn. Thus it appears 
that these neuroproteins (SP and CGRP) are not related 
to chronic pain per se; it is rather the breakdown of the 
equilibrium between ascending primary nociceptive im- 
pulses and descending serotoninergic impulses which 
normally would release endogeneous opiates, as sug- 
gested originally by Jessell and Iversen (1977). It has to 
be assumed that depletion of "pain-related neuropep- 
tides" and the consequent atrophic alterations of the 
terminals make the effect of encephalinergic terminals 
impinging upon the primary central nerve terminals inef- 
fective; hence the persisting ongoing activation of the as- 
cending pathway results first in subacute and later, in 
chronic pain. In order to prove or to disprove such an 
interpretation of the experimental data, electro-cortico- 
graphic recordings from the somatosensory cortex of ani- 
mals suffering chronic pain are in progress in our 
laboratory. 
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